|
End-of-day quote
Nasdaq
18/11/2026
|
5-day change | 1st Jan Change | ||
| 1.850 USD | +7.56% |
|
-18.86% | -79.51% |
| 17/11 | EnGene Therapeutics Inc. Presents at UBS Global Biopharma Conference 2026, Nov-16-2026 03:20 PM | |
| 13/11 | Leerink Partners Upgrades enGene to Outperform From Market Perform, $5 Price Target | MT |
| Market Cap | 118M 107M 99.48M 89.98M 169M 11.02B 177M 1.2B 477M 5.95B 443M 433M 18.86B | P/E 2026 * |
-0.96x | P/E 2027 * | -1.1x |
|---|---|---|---|---|---|
| Enterprise Value | -66.57M -60.66M -56.15M -50.79M -95.28M -6.22B -99.72M -679M -269M -3.36B -250M -245M -10.64B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.3x |
| Free-Float |
99.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ENGN | End-of-day quote | |
| ENGN | Real-time | ||
| S0N0 | Delayed |
Last Transcript: enGene Therapeutics Inc.
| 1 day | +7.56% | ||
| 1 week | -18.86% | ||
| Current month | +20.92% | ||
| 1 month | +17.09% | ||
| 6 months | +20.92% | ||
| Current year | -79.51% |
| 1 week | 1.65 | 2.36 | |
| 1 month | 1.45 | 2.51 | |
| Current year | 1.4 | 12.25 | |
| 1 year | 1.4 | 12.25 | |
| 3 years | 1.4 | 18.4 | |
| 5 years | 1.4 | 47.17 | |
| 10 years | 1.4 | 47.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ronald Cooper
CEO | Chief Executive Officer | 63 | 22/07/2024 |
Kathleen Richton
DFI | Director of Finance/CFO | 48 | 16/07/2026 |
Jason Duncan
ADM | Chief Administrative Officer | 52 | 09/11/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Gerry Brunk
BRD | Director/Board Member | 57 | 08/08/2023 |
Lota Zoth
BRD | Director/Board Member | 66 | 18/12/2023 |
Paul Hastings
BRD | Director/Board Member | 66 | 15/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/9/26 | Buy | Chief Technology Officer | 5,102 | 0.0076% | ||
| 16/7/26 | Other | Interim Chief Business Officer | 75,000 | 0.1120% | ||
| 16/7/26 | Other | Chief Financial Officer | 0 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +7.56% | -18.86% | -72.63% | -75.82% | 118M | ||
| +0.19% | -3.96% | +54.92% | +69.15% | 65.42B | ||
| -0.14% | -3.20% | +7.62% | +89.74% | 58.91B | ||
| +0.06% | +0.15% | +25.94% | +87.89% | 55.24B | ||
| -0.97% | -3.91% | +12.98% | +113.88% | 45.66B | ||
| -2.83% | -7.58% | +15.21% | +22.34% | 41.29B | ||
| +3.61% | +2.63% | +21.96% | +46.39% | 36.82B | ||
| -0.24% | -9.59% | +126.05% | +647.44% | 34.48B | ||
| +0.03% | -0.93% | +76.71% | +57.74% | 32.5B | ||
| +20.58% | +22.35% | -29.03% | +482.03% | 31.69B | ||
| Average | +2.78% | -2.24% | +23.97% | +154.08% | 40B | |
| Weighted average by Cap. | +1.55% | -0.98% | +33.36% | +154.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 4.68M 4.26M 3.95M 3.57M 6.69M 437M 7.01M 47.69M 18.92M 236M 17.55M 17.18M 748M |
| Net income | -125M -114M -106M -95.54M -179M -11.7B -188M -1.28B -506M -6.32B -470M -460M -20.02B | -118M -108M -99.72M -90.21M -169M -11.04B -177M -1.21B -478M -5.97B -444M -434M -18.9B |
| Net Debt | -185M -168M -156M -141M -264M -17.23B -276M -1.88B -746M -9.31B -692M -678M -29.5B | -74.46M -67.84M -62.8M -56.81M -107M -6.95B -112M -759M -301M -3.76B -279M -274M -11.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/11/26 | USD 1.760 | -4.86% | 1,008,095 |
| 18/11/26 | USD 1.850 | +7.56% | 2,805,877 |
| 17/11/26 | USD 1.720 | -8.99% | 1,730,243 |
| 16/11/26 | USD 1.890 | -21.58% | 1,994,847 |
| 13/11/26 | USD 2.410 | +5.70% | 3,721,293 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ENGN Stock
Select your edition
All financial news and data tailored to specific country editions
















